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SUMMARY
Timely diagnosis of the nematode Angiostrongylus vasorum in dogs is important in view of severe and permanent lung and
cardiovascular lesions that may occur. The performance of the classical Baermann coprological method was compared with
ELISAs for the serological detection of circulating antigen and specific antibodies and with Polymerase chain reaction
(PCR) performed on EDTA blood, feces and tracheal swabs of serial samples from experimentally inoculated dogs
over 13 weeks post inoculation (wpi) (n= 16) and following anthelmintic treatment (n= 6). Patency was observed from
6·7 to 7·6 wpi in all dogs, Baermann results were then mostly positive (116/119, 97%) during the patent period, with
wide variations in the numbers of first stage larvae numbers. Blood PCR was tested positive on 1–2 occasions in 11/16
dogs in the pre-patent period, while all tested positive by antibody-detection ELISA by 6 wpi. The proportion of dogs
testing positive by fecal PCR and antigen-detection ELISA rose early in the patent period. Tracheal swabs were occasion-
ally DNA-positive in 3/16 dogs starting from 10 wpi. Following treatment, larval excretion stopped within 3 weeks and
blood PCR results became negative within 1 week (5/6 dogs), while 4/6 dogs were positive for parasite DNA in tracheal
swabs. Parasite antigen and specific antibodies both persisted in the blood for 3–9 weeks after treatment, with average
optical densities and the proportion of positive dogs falling gradually, while results using other tests were much more vari-
able. Results indicate that the earliest and most consistent results are obtained by the ELISAs, which can also be used for
monitoring dogs after anthelmintic treatment.
Key words: Angiostrongylus vasorum, dog, copromicroscopy, serology, antigen detection, antibody detection, PCR,
tracheal swabs, fecal samples, blood.
INTRODUCTION
Angiostrongylus vasorum is a metastrongylid nema-
tode residing in the right heart and pulmonary arter-
ies of its definitive canid host (Guilhon, 1963). It is a
cause of respiratory distress and diverse other clinic-
al signs (Koch and Willesen, 2009), and can be
severe or even fatal in dogs (Cury and Lima, 1996;
Staebler et al. 2005). The recent increase in reports
of canine angiostrongylosis throughout Europe
(Morgan and Shaw, 2010) and North America
(Conboy, 2011; Kistler et al. 2014) suggests spread
and/or increased awareness of this emerging parasit-
ic disease. Accordingly, novel highly sensitive and
specific diagnostic methods have been developed,
to complement the currently used larval migration
techniques such as the Baermann–Wetzel technique
(Deplazes et al. 2013) for the detection of first stage
larvae (L1) in fecal samples. While simple fecal
smears may be used for fast diagnosis in general
practice in strongly suspected cases (Humm and
Adamantos, 2010), and fecal flotation methods
such as FLOTAC can also work reasonably well
(Schnyder et al. 2010b), copromicroscopic methods
in general suffer from the problem of reduced sensi-
tivity due to low or intermittent larval shedding
(Oliveira-Junior et al. 2006) especially in cases of
low worm burdens. The sensitivity of larval detec-
tion is also restricted when analysing posted fecal
samples that arrive with some delay at the laboratory
and therefore containing deformed or dead larvae.
Also, pre-patent infections are not detected.
Furthermore, since other lung-worm larvae such as
Crenosoma vulpis and Filaroides spp. (McGarry and
Morgan, 2009; Deplazes et al. 2013) occur in dog
feces, specificity may depend on the expertise of
diagnostic staff.
Recently developed serological methods (Schnyder
et al. 2011; Schucan et al. 2012) for the detection of
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A. vasorum infected dogs byELISAs (Enzyme-linked
Immunosorbent Assays) represent a valid alternative
for diagnosis in individuals and have been evaluated
and used in the field in large scale epidemiological
surveys (Guardone et al. 2013; Schnyder et al.
2013a, b).
A further alternative for the diagnosis of A.
vasorum infected dogs is provided by molecular
tools such as Polymerase chain reaction (PCR). In
particular, a PCR procedure developed to facilitate
the processing of larger fecal volumes was described
as a non-invasive tool for wildlife surveillance in
foxes (Al-Sabi et al. 2010) and may be recommended
for prevalence studies in intermediate mollusc hosts
(Ferdushy et al. 2009). Recently developed real-time
PCR assays were able to detect blood, feces or inter-
mediate host tissue spiked with a single A. vasorum
L1 with high specificity. Discordance between
blood and fecal PCR (and Baermann) results in nat-
urally infected dogs was suggested to be due to the
intermittent presence of circulating DNA (Jefferies
et al. 2009). The authors suggested that accurate de-
tection limits would be obtained through the use of
samples from experimentally infected animals after
known inoculation times.
The aim of this study was to compare different
diagnostic methods for A. vasorum after experimen-
tal infection, using blood, fecal and tracheal swab
samples. By taking serial samples, tests are compared
in relation to suitability at different stages of clinical
infection, as well as providing possible insights into
the dynamics of the infection process.
MATERIALS AND METHODS
Dog sera, tracheal swabs, fecal samples
A total of 16 dogs were experimentally inoculated
with 200 third stage larvae (L3) of A. vasorum har-
vested from experimentally infected Biomphalaria
glabrata snails as previously described (Schnyder
et al. 2009). Six dogs were treated with imidacloprid
10 mg kg−1bodyweight (BW)/moxidectin2·5 mg kg−1
BW spot-on (Advocate®, Bayer Animal Health) 13
weeks (88 days) post inoculation (wpi). Ethical clear-
ance for the study was obtained from the Cantonal
Veterinary Office of Zurich (permission number
185/2008); the dogs were facility-born animals and
the study was primarily conducted to investigate
drug efficacy for parasite clearance, with the present
data supporting that aim and utilizing the same
filed permissions. Due to further research purposes
(i.e. cardiology studies – see Matos et al. 2012 – and
production of excretory/secretory antigens), 10 dogs
were left untreated and 9 of them were necropsied
between11and51 wpi.Atnecropsy, thewormburden
was determined through dissection and retrograde
lung perfusion, as previously described (Schnyder
et al. 2009).
Peripheral blood was regularly (mostly every 1–2
weeks) collected from the jugular vein into BD
Vacutainer® tubes (Becton Dickinson, Franklin
Lakes, NJ, USA) for collection of EDTA (Ethylene-
diaminetetraacetic acid) anticoagulated samples (for
PCR) and serum samples (for ELISAs). Fecal
samples and tracheal swabswere collected contempor-
aneously. The number of L1 per gram of feces (LPG)
was determined on each occasion by the Baermann–
Wetzel technique (Deplazes et al. 2013) on 10 g of
fresh feces, with remaining feces, blood, serum and
swabs frozen at −20 °C pending processing.
ELISAs for the detection of A. vasorum circulating
antigen and specific antiparasitic antibodies
A sandwich-ELISA based on monoclonal and poly-
clonal antibodies directed against A. vasorum adult
excretory/secretory (E/S) – antigen and having a sen-
sitivity of 95·7% and specificity of 94·0% was per-
formed for detection of circulating antigen as
described in Schnyder et al. (2011). For detection
of specific antibodies an ELISA using A. vasorum
adult E/S antigen with a sensitivity of 85·7% and a
specificity of 98·8% (Schucan et al. 2012) was
used. Absorbance values were read at 405 nm
with a Multiscan RC ELISA reader (Thermo
Labsystems, Helsinki, Finland). All test runs included
a background control, a conjugate control, three
positive control sera from three experimentally
infected dogs and two negative control sera from
uninfected dogs. The cut-off value of each test was
determined as described: for the antigen detection
ELISA, the cut-off was determined using the mean
value of optical density (OD, A405 nm) plus 3 standard
deviations (S.D.) of 30 sera from randomly chosen
samples submitted to the Veterinary Laboratory of
the Veterinary Hospital of the Vetsuisse Faculty of
the University of Zurich for various reasons not
related to suspected parasitological infections (cut-off
OD=0·159). For the antibody detection ELISA, 30
sera from healthy blood donor dogs, which were sub-
jected to intense and regular clinical and laboratory
screening analyses, and not originating from a known
A. vasorum endemic area in Switzerland, were used
to determine the cut-off value. Four S.D. were
applied in this case for better discrimination between
positive and negative sera, based on the results with
predefined sera (cut-off OD=0·310).
PCR
DNA extraction and real-time PCR were performed
according to the method described by Jefferies et al.
(2009). Briefly, DNA was extracted using a DNEasy
blood and tissue kit (Qiagen, Germany, for whole
blood and tracheal swabs) and QIAamp stool kit
(Qiagen, Germany, for feces) according the manu-
facturers’ instructions. Specific primers designed to
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amplify a region of the second ribosomal transcribed
spacer (ITS-2) of A. vasorum were used in a real-
time PCR with defined procedures and cut-off
limits. This assay has previously been shown to be
highly specific for A. vasorum and to detect a single
molecule of plasmid DNA or a single L1 (Jefferies
et al. 2009).
RESULTS
Patency (L1 detected in feces) was observed starting
from 6·7 to 7·6 wpi in all dogs, and larval excretion
in dogs treated at 13 wpi stopped within 3 weeks
after treatment. The different tests detected infec-
tion at different stages, and varied in the internal
(within-dog over time) and external (between-dog)
consistency of results. Thus, an example profile
from an individual dog is presented in Table 1.
Infection in this case was first detected by blood
PCR approximately 2 weeks after infection, but
blood PCR results were inconsistently positive
after this time up until treatment and 5 weeks there-
after, when the test became consistently negative.
Antibodies against A. vasorum were also detected
during the pre-patent period, from 4 weeks after in-
fection, and were consistently present at above-
threshold levels until 5 weeks after treatment,
when OD dropped below the threshold for a positive
result. Circulating antigens in serum, and L1 and
parasite DNA in the feces were observed from
around 7 wpi, and declined over 2–4 wpi.
All dogs were found to shed L1 by 8 weeks after in-
oculation, by which time variable proportions of
other tests were positive (Fig. 1, Table 2). Baermann
results were then mostly positive during the patent
period, though occasional negative tests were
observed and the LPG varied widely between and
within dogs. Antibody-detection ELISA and blood
PCR tested positive in some dogs in the pre-patent
period, with the proportion of dogs testing positive
by larval migration, fecal PCR and antigen-detection
ELISA rising early in the patent period. All the
infected dogs were tested positive by antibody-detec-
tion ELISA by 6 wpi and remained consistently so
until after treatment (or the end of the experiment
in untreated dogs that remained infected). All dogs
also were antigen-positive at 11 wpi and remained
so until after treatment (or the end of the experiment
in untreated dogs that remained infected). In contrast,
results using other tests were much more variable
(Table 2). Following treatment at 13 wpi (n= 6
dogs), blood PCR results became negative within 1
week, with one positive result observed in a single
dog (1/6) 4 weeks after treatment. The proportion
of dogs excreting L1 declined over the 3 weeks fol-
lowing treatment. In contrast, dogs testing positive
for parasite DNA in tracheal swabs increased from
3/16 dogs being occasionally positive before 12 wpi
to 4/6 dogs being positive after treatment until 3
weeks later (15 wpi), while also 4 out of 10 untreated
dogs were irregularly positive until 15 wpi. Parasite
antigen and specific antibodies both persisted in
the blood up to 7 and 9 weeks, respectively, after
treatment (Table 2), with average ODs and the pro-
portion of positive dogs falling gradually in the 5
weeks after treatment over which monitoring contin-
ued for all 6 dogs (Fig. 1). Three untreated dogs
spontaneously ceased to excrete L1 during the ex-
periment, in weeks 15 (n = 2) and 17 (n= 1) after in-
oculation, and nowormswere found on post-mortem
examination following euthanasia (n= 2, 9 days after
first negative Baermann’s result). In these dogs,
blood PCR rapidly became negative after cessation of
larval shedding, while antibody and antigen ELISAs
were still positive. Three of the 6 treated dogs were
euthanized at the end of the experiment, and no
worms were recovered after dissection.
The number of L1 recovered by Baermann exam-
ination varied widely between dogs, and fluctuated
over time within individual dogs. Thus, although
all dogs were inoculated with 200 L3, LPG during
the patent period varied from 0 to 2010 g−1 (mean
122, S.D. 362). Average LPG over the patent period
varied between dogs from 0·25 to 456. The number
of worms recovered from untreated dogs that
retained their infections and were subjected to post-
mortem worm counts (n= 7) also varied (mean 35,
range 13–68, S.D. 17), but the coefficient of variation
(CV) (0·49, n = 7) was inferior to that of average
larval count over the patent period between dogs
(1·69, n = 16) as well as to that of weekly larval
count in individual dogs over the patent period
(range 0·54–2·07, median 1·28, n = 16). Results of
other tests were less variable within dogs over time
than was LPG (median CV and range: for blood
PCR Ct (Cycle threshold) = 0·033; 0·003–0·066,
for fecal PCR Ct = 0·16; 0·14–0·20, Ag ELISA
OD= 0·55; 0·22–0·75, Ab ELISA OD= 0·10;
0·09–0·17). There was no correlation between any
test result when averaged over the patent period
and the post-mortem worm count in the same
individual (n = 7).
DISCUSSION
Early diagnosis of infection with A. vasorum could
be important in clinical case management, since
pre-patent lung pathology and clinical disease can
occur (Schnyder et al. 2009). The present results
indicate that circulating specific antibodies and para-
site DNA in blood can be detected during the pre-
patent period. The earliest indicator of infection
was provided in a single dog by blood PCR 2 wpi,
but this was not a consistent finding, with all four
positive blood PCR tests in the first 5 weeks of infec-
tion being followed by negative results in the same
dogs. It is likely that these early positive PCR
results relate to DNA originating from L3 during
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Table 1. Example time-course of test results from a selected individual dog during infection with Angiostrongylus vasorum before (a) and after (b) anthelmintic
treatment 13 weeks after inoculation. Inoculation with infectious third stage larvae occurred on day zero. ‘+’= positive results, ‘−’= negative results, blank cells =
the test was not performed. Data are illustrative of individual level information that was subsumed into the group-level summaries presented elsewhere.
(a) (Prior to treatment)
Day after inoculation















Blood PCR (Ct values)
c + (36·84) −0 −0 −0 −0 + (35·81) −0 +41·71 −0 −0 +35·50
Fecal PCR (Ct values)
c +40·52 +34·53 +40·69
Swab PCR (Ct values)
c
−0 −0 −0 −0 −0 −0 +39·01 −0
Baermann (LPG)d −0 −0 −0 −0 −0 −0 −0 +0·1 +1·0 +1·1 +11·2 +14·4 +59·2
AG ELISA (OD-value)e −0·057 −0·067 −0·066 −0·052 −0·066 −0·065 −0·051 −0·063 +0·177 +0·953 +1·439 +1·610 +1·633
AB ELISA (OD-value)f −0·005 −0·018 −0·125 −0·289 +0·433 +0·927 +1·272 +1·252 +1·138 +0·935 +0·650 +0·873 +0·725
(b) After treatment
Day after inoculation (week after treatment)a 97 (2) 104 (3) 111 (4) 118 (5) 132/133 (7) 146 (9) 160 (11) 174 (13) 188 (15) 230 (21)
Blood PCR (Ct values)
c
−0 −0 −0 +40·58 −0 −0 −0 −0
Fecal PCR (Ct values)
c +35·51 −0 −0 −0 −0 −0 −0 −0 −0 −0
Swab PCR (Ct values)
c
−0
Baermann (LPG)d +291·6 +0·1 −0 −0 −0 −0 −0 −0 −0 −0
AG ELISA (OD-values) +1·575 +1·370 +0·707 −0·068 −0·062 −0·056 −0·056 −0·063
AB ELISA (OD-values)f +0·604 +0·493 +0·425 +0·348 −0·183 −0·139
PCR, polymerase chain reaction; LPG, larval density per gram of feces; OD, optical density
a Sampling for different tests sometimes occurred over consecutive days, and week markers are approximate.
b Treatment with Advocate® (Bayer Animal Health, imidacloprid 10 mg kg−1 body weight (BW)/moxidectin 2·5 mg kg−1 BW spot-on) 88 days after inoculation.
c Cycle threshold of the quantitative real-time PCR (Jefferies et al. 2009).
d Number of larvae per gram of feces obtained by Baermann–Wetzel examination (Deplazes et al. 2013).
e Detection of circulating antigen by ELISA (Schnyder et al. 2011), with optical density absorbance values read at 405 nm, cut-off value = 0·159.
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migration and maturation, in which case inconsist-
ent presence in circulating blood is not surprising.
Specific anti-A. vasorum antibodies, on the other
hand, were detected at above-threshold levels from
week 3 in some dogs, and from week 5 in all dogs,
and once positive remained positive throughout the
patent period. Ab-detection ELISA is therefore the
most promising test for identifying dogs at an early
stage of infection.
Although diagnosis early in the course of infection
might confer clinical advantages in some cases,
natural infections are likely to present clinically at a
wide range of intervals following infection. The
most useful diagnostic tests to support infection
are therefore those that are most consistently positive
in genuinely infected dogs. This is especially so
because in canine angiostrongylosis, the clinical con-
sequences of failing to diagnose an infection are
likely to be higher than those of unnecessarily treating
an uninfected dog (Koch andWillesen, 2009;Morgan
and Shaw, 2010; Paradies et al. 2013). The present
study identified very high variation in test results
that relied on the presence of parasite material in
the feces (Baermann–Wetzel examination and fecal
PCR) or sputum (tracheal swab PCR), or parasite
DNA in the blood (blood PCR). In contrast,
antibody and antigen detection ELISAs were con-
sistently positive in all dogs throughout the patent
period, and confirmed to be useful in a clinical
setting. These results also confirm previous studies
showing that the antigen detection ELISA was
able to detect circulating antigen already starting
Fig. 1. The detection ofAngiostrongylus vasorum in experimentally infected dogs using different methods during the early
phase of infection (n= 16), and after anthelmintic treatment (n= 6; arrow) with imidacloprid-moxidectin (Advocate®) in
week 13.
Table 2. Consistency of test results in detecting infection in dogs experimentally inoculated with
Angiostrongylus vasorum (n= 16 inoculated; of which n = 6 treated with the anthelmintic imidacloprid 10 mg




















Blood PCR 6·3 (2–10) 0·78 (0·45–1) 120 0·70 1·0 (1–5)
Fecal PCR 9·1 (8–11) 0·91 (0·5–1) 58 0·84 2·0 (−)
Swab PCR 12·9 (10–15) 0·71 (0·5–1) 16 0·69 2·7 (2–3)
Baermann 7·4 (7–8) 0·95 (0·4–1) 119 0·97 2·2 (2–3)
AG ELISA 8·7 (7–11) 1 (−) 97 1 4·0 (3–7)
AB ELISA 4·6 (3–6) 1 (−) 158 1 5·7 (3–9)
PCR, polymerase chain reaction
a For test details see Table 1.
b Week after infection in which each test returned a positive result, on average (range in brackets).
c Average proportion of each repeated test that was positive within individuals, after the first positive and until treatment,
euthanasia or spontaneous clearance of worms (range in brackets).
d Total number of each test that was run after the first positive.
e Proportion of all dogs that tested positive of the total number of tests that was run after the first positive.
f The average number of weeks after treatment that individual dogs still tested positive (range in brackets).
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from 5 weeks after experimental inoculation of dogs
(Schnyder et al. 2011) and the specific antibody
ELISA starting 2–3 weeks after inoculation (Schucan
et al. 2012).
When using antibody detection as a clinical diag-
nostic test in an at-risk population, the persistency
of antibodies in recently treated dogs needs to be
considered. In the present study, dogs remained
positive for antibodies for 3–9 weeks after treatment,
more than for any other test. However, all tests
remained positive in some dogs for a number of
weeks after treatment (e.g. 5 weeks for circulating
antigen and 4 weeks for blood PCR). The fecal
tests showed the fastest decline in number of posi-
tives after treatment (1 and 2 weeks for fecal PCR
and Baermann–Wetzel examination, respectively),
but the high variation in results from those tests
during patency weaken their interpretation as a test
for successful treatment, unless multiple examina-
tions are performed. Monitoring of dogs after treat-
ment for successful parasite clearance could
therefore make use of any of the tests evaluated,
but perhaps most usefully would track the dis-
appearance of circulating antigen and/or antibodies
after the appropriate time after treatment.
PCR was described to screen throat swabs for
Aelurostrongylus abstrusus in cats (Traversa et al.
2008), and a similar procedure for dogs infected
with A. vasorum was considered. In this study, the
number of dogs testing positive for A. vasorum
DNA in sputum paradoxically increased after an-
thelmintic treatment. This could be explained by
the presence of genetic material from dead and de-
grading worms, especially larvae, being carried up
the bronchial muco-ciliary escalator. However, an
increase in the number of positive tests occurred
after 12 weeks in untreated as well as treated dogs,
for which there is no obvious explanation. The late
onset and highly inconsistent detection of DNA-
positive tracheal swabs suggest that this test would
be of little use in diagnosing clinically affected dogs
in practice, although PCR could be useful to
confirm the identity of larvae discovered on airway
cytology. Detection of DNA could also be enhanced
by taking larger, well-mixed sputum samples,
though the ease of sampling is likely to vary
between individual dogs and clinical presentations.
The timing of serial test results in the present study
appears to confirm existing understanding of the
parasite life cycle and infection process. Thus, occa-
sional and transient positive blood PCR results
could indicate migrating larvae, with this process
also triggering a humoral immune response and grad-
ually increasing production of specific antibodies.
The other tests (with exception of PCR with tracheal
swabs) became positive in most dogs around week 7,
coinciding with establishment of adult parasites and
production of eggs and L1, accompanied by release
of parasite antigen and DNA into the circulation
and trachea. The presence of circulating DNA of
A. vasorum is additionally sustained by the occurrence
of ectopic localization of the parasite in different
organs and tissues, as reported for adult worms
(King et al. 1994; Cury and Lima, 1996; Oliveira-
Junior et al. 2004) and L1 (Oliveira-Junior et al.
2004). The appearance of L1 in the feces 7–8 wpi is
consistent with existing data on the pre-patent
period in this species (Guilhon, 1963; Schnyder et al.
2010a). The fast disappearance of parasite DNA
from circulating blood after anthelmintic treatment
seems to suggest that PCR mainly detects DNA that
is shed from living worms, e.g. during egg ejection
or while producing E/S antigen, rather than shed
passively from worms in the blood vessels, in which
case one might expect positive results for some
time after treatment, as cells are lost from degrading
worms. The longer persistence of detectable parasite
antigen after treatment is consistent with such
passive shedding into the blood. Interestingly, 3/10
untreated dogs spontaneously lost their worm
burden, accompanied by a decline in positive test
results similar to that following treatment. The
mechanisms involved in parasite clearance, and their
relevance to natural infection and disease, are not
known.
In total, 97% of fecal samples during the patent
period yielded detectable L1, in contrast to previous
reports of intermittent shedding of L1 in experimen-
tally infected dogs (Oliveira-Junior et al. 2006). The
average number of larvae recovered varied very
widely between dogs, much more so than the
number of adult worms recovered from those dogs
subjected to post-mortem examination. Moreover,
LPG fluctuated considerably over the course of in-
fection in individual dogs. Given the additional inac-
curacies conferred in practice by less sensitive fecal
tests, threats to larval viability during transit, and
variable operator experience, this could limit the
sensitivity of diagnostic tests based on larval enu-
meration. Nevertheless, based on the here presented
results, larval isolation through the Baermann
method can still be recommended in combination
with multiple fecal examinations by collection of
feces over 3 consecutive days, as reported from
recent prevalence studies performed with the
Baermann funnel technique (Barutzki and Schaper,
2009; Paradies et al. 2013). More recent fecal exam-
ination methods such as the sensitive flotation
method FLOTAC (Schnyder et al. 2010b) might
improve performance. Fecal PCR appeared to give
more consistent results than larval counts in the
present study, but some negative results were
nevertheless obtained despite the proven presence
of adult worms. Fecal PCR was also shown to
give variable results in natural infections (Jefferies
et al. 2009).
In conclusion, the present study evaluated an
array of potential diagnostic tests in a group of
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dogs experimentally infected for the purpose of
a trial of anthelmintic efficacy. Tests varied in
the timing and consistency of positive results.
Circulating parasite antigen and specific antibodies
in serological samples appeared early in the course
of infection and remained persistently above the
positive cut-off throughout patency, before declin-
ing in treated dogs over the few weeks following
administration of anthelmintic. Other tests gave
more variable results over the patent period. It is
likely that in clinical practice, different tests will
have diagnostic value in various cases, alone or in
combination (Jefferies et al. 2011; Schnyder et al.
2014). In respect thereof, the recent commercial
availability of a rapid in-clinic assay (Angio
Detect™ Test, IDEXX Laboratories, Westbrook,
Maine, USA) for the serological detection of circu-
lating antigen showed a good sensitivity and a very
high specificity (Schnyder et al. 2014), and may
represent a valid alternative to be broadly applied
in veterinary practices in dogs with suspected
canine angiostrongylosis. With this test, earliest
positive results were obtained starting from 9 wpi,
while after anthelmintic treatment seropositive dogs
turned negative again within 3–7 weeks after treat-
ment. The direct comparison with the ELISA
detecting circulating antigen showed a delay of
approximately 3–4 weeks for antigen detection by
the Angio Detect™ Test. Contemporaneously, the
utilization of broadly applied ELISAs in epidemio-
logical surveys can improve the evidence base avail-
able to practitioners, especially concerning local risk
of disease (Guardone et al. 2013; Schnyder et al.
2013a, b).
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